US Ablation Technology Market worth US$3.87 billion by 2030 with 9.6% CAGR | MarketsandMarkets™

Browse in-depth TOC on "US Ablation Technology Market" Browse in-depth TOC on "US Ablation Technology Market" 200 - Tables 25 - Figures By Based on segment,In the US, the pulsed field ablation market is poised to be the fastest growing technology segment owing to their superior safety profile (as compared to thermal ablation), rising prevalence of CVDs along with rising adoption of PFA in fibrillation treatment, and supportive regulations. By Based on application,  the US...

DELRAY BEACH, Fla., 10/04/2025 (informazione.news - comunicati stampa - salute e benessere)

In the US, the pulsed field ablation market is poised to be the fastest growing technology segment owing to their superior safety profile (as compared to thermal ablation), rising prevalence of CVDs along with rising adoption of PFA in fibrillation treatment, and supportive regulations.

 the US ablation technology market is segmented into CVDs, cancer, ophthalmology, pain management, OB/gyn, urology, orthopaedics, cosmetic/aesthetic, and other applications. Some key factors propelling the segment expansion are increasing prevalence of cardiovascular disease, adoption of novel ablation technologies such as PFA, and supportive reimbursement landscape. 

Prominent players in the ablation technology market include Medtronic plc, Boston scientific, Johson & Johson, Abbott, Atricure, Angiodynamics, Conmed, among others.

The report details the drivers, restraints, challenges, and opportunities pertaining to the US ablation technology market and forecasts the market till 2030. It also provides a qualitative and quantitative description of different segments considered for the US ablation technology market. The report gives a detailed overview of the market across the US.

For more information,

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, , and . With a , we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

 

 

 

View original content:https://www.prnewswire.co.uk/news-releases/us-ablation-technology-market-worth-us3-87-billion-by-2030-with-9-6-cagr--marketsandmarkets-302425424.html